Evolus Newsroom

H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $27

Futu NewsOct 3 18:31

Evolus Is Maintained at Overweight by Barclays

Dow JonesSep 14 00:09

Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $25

Futu NewsSep 13 21:32

Stifel Nicolaus Reaffirms Their Buy Rating on Evolus (EOLS)

TipRanksSep 13 20:37

Needham Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 13 18:31

Evolus Price Target Maintained With a $22.00/Share by Needham

Dow JonesSep 13 18:02

Evolus Buy Rating Justified by Strong Market Positioning and Growth Projections

TipRanksSep 13 17:47

Barclays Maintains Evolus(EOLS.US) With Buy Rating, Raises Target Price to $20

Futu NewsSep 13 15:32

Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $23

Futu NewsSep 10 17:32

Evolus Analyst Ratings

BenzingaSep 10 01:02

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Evolus (EOLS) and Humana (HUM)

TipRanksAug 5 15:01

A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $16 to $27

Futu NewsAug 2 21:04

A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $22 to $27

Futu NewsAug 1 21:03

Evolus (EOLS) Receives a Buy From Stifel Nicolaus

TipRanksAug 1 20:22

Evolus Price Target Maintained With a $22.00/Share by Needham

Dow JonesAug 1 17:46

Evolus Rides High on Jeuveau Sales Surge and Financial Milestones: A Bullish Buy Rating

TipRanksAug 1 17:39

Needham Reiterates Buy on Evolus, Maintains $22 Price Target

BenzingaAug 1 17:37

Evolus Analyst Ratings

BenzingaAug 1 17:35

Evolus Outperforms With Strong Q2 Revenue and Raised Guidance: A Positive Outlook Reaffirms $23 Price Target

TipRanksAug 1 15:36

Barclays Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $16

Futu NewsJul 31 16:35